Wan C, Wang H, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC. SJS/TEN 2019: from science to translation. J Dermatol Sci. 2020;98:2–12. https://doi.org/10.1016/j.jdermsci.2020.02.003.

Article  PubMed  PubMed Central  Google Scholar 

Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39. https://doi.org/10.1186/1750-1172-5-39.

Article  PubMed  PubMed Central  Google Scholar 

Mahar PD, Wasiak J, Hii B, Cleland H, Watters DA, Gin D, Spinks AB. A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres. Burns. 2014;40:1245–54. https://doi.org/10.1016/j.burns.2014.02.006.

Article  PubMed  Google Scholar 

Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Kokaze A. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016–2018. J Dermatol Sci. 2020;100:175–82. https://doi.org/10.1016/j.jdermsci.2020.09.009.

Article  PubMed  Google Scholar 

Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16:297–306. https://doi.org/10.1097/01.fpc.0000199500.46842.4a.

Article  CAS  PubMed  Google Scholar 

Ueta M. Genetic predisposition to Stevens-Johnson syndrome with severe ocular surface complications. Cornea. 2015;34:S158–65. https://doi.org/10.1097/ICO.0000000000000605.

Article  PubMed  Google Scholar 

Ueta M. Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions. Taiwan J Ophthalmol. 2016;6:108–18. https://doi.org/10.1016/j.tjo.2016.06.001.

Article  PubMed  PubMed Central  Google Scholar 

Das SK, Sampath A, Zaman SU, Pati AK, Atal S. Genetic predisposition for the development of lamotrigine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. Per Med. 2023;20:201–13. https://doi.org/10.2217/pme-2022-0126.

Article  CAS  PubMed  Google Scholar 

Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115:149–53. https://doi.org/10.1046/j.1523-1747.2000.00061.x.

Article  CAS  PubMed  Google Scholar 

Roujeau JC, Bastuji-Garin S. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf. 2011;2:87–94. https://doi.org/10.1177/2042098611404094.

Article  PubMed  PubMed Central  Google Scholar 

Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG. Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis—ABCD-10. JAMA Dermatol. 2019;155:448–54. https://doi.org/10.1001/jamadermatol.2018.5605.

Article  PubMed  PubMed Central  Google Scholar 

von Wild T, Stollwerck PL, Namdar T, Stang FH, Mailänder P, Siemers F. Are multimorbidities underestimated in scoring systems of Stevens-Johnson syndrome and toxic epidermal necrolysis like in SCORTEN? Eplasty. 2012;12: e35.

Google Scholar 

Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M. Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States. J Invest Dermatol. 2018;138:2315–21. https://doi.org/10.1016/j.jid.2018.04.027.

Article  CAS  PubMed  Google Scholar 

Yamane Y, Matsukura S, Watanabe Y, Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z, Aihara M. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients–Treatment and outcome. Allergol Int. 2016;65:74–81. https://doi.org/10.1016/j.alit.2015.09.001.

Article  CAS  PubMed  Google Scholar 

Watanabe T, Go H, Saigusa Y, Takamura N, Watanabe Y, Yamane Y, Totsuka M, Ishikawa H, Nakamura K, Matsukura S, Kambara T, Takaki S, Yamaguchi Y, Aihara M. Mortality and risk factors on admission in toxic epidermal necrolysis: a cohort study of 59 patients. Allergol Int. 2021;70:229–34. https://doi.org/10.1016/j.alit.2020.11.004.

Article  CAS  PubMed  Google Scholar 

Koh HK, Fook-Chong S, Lee HY. Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis. JAMA Dermatol. 2020;156:1294–9. https://doi.org/10.1001/jamadermatol.2020.3654.

Article  PubMed  Google Scholar 

Hama N, Sunaga Y, Ochiai H, Kokaze A, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Hasegawa A, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Brüggen MC, Feingold IM, Jeschke MG, Dodiuk-Gad RP, Oppel EM, French LE, Chen WT, Chung WH, Chu CY, Kang HR, Ingen-Housz-Oro S, Nakamura K, Sueki H, Abe R. Development and validation of a novel score to predict mortality in Stevens-Johnson syndrome and toxic epidermal necrolysis: CRISTEN. J Allergy Clin Immunol Pract. 2023;11:3161–8. https://doi.org/10.1016/j.jaip.2023.07.001.

Article  PubMed  Google Scholar 

Koh HK, Fook-Chong SMC, Lee HY. Improvement of mortality prognostication in patients with epidermal necrolysis: the role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN). JAMA Dermatol. 2022;158:160–6. https://doi.org/10.1001/jamadermatol.2021.5119.

Article  PubMed  Google Scholar 

Burkhart KK, Abernethy D, Jackson D. Data mining FAERS to analyze molecular targets of drugs highly associated with Stevens-Johnson syndrome. J Med Toxicol. 2015;11:265–73. https://doi.org/10.1007/s13181-015-0472-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abe J, Umetsu R, Mataki K, Kato Y, Ueda N, Nakayama Y, Hane Y, Matsui T, Hatahira H, Sasaoka S, Motooka Y, Hara H, Kato Z, Kinosada Y, Inagaki N, Nakamura M. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database. J Pharm Health Care Sci. 2016;2:14. https://doi.org/10.1186/s40780-016-0048-5.

Article  PubMed  PubMed Central  Google Scholar 

Low YS, Caster O, Bergvall T, Fourches D, Zang X, Norén GN, Rusyn I, Edwards R, Tropsha A. Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome. J Am Med Inform Assoc. 2016;23:968–78. https://doi.org/10.1093/jamia/ocv127.

Article  PubMed  Google Scholar 

Chan R, Wei CY, Chen YT, Benet LZ. Use of the biopharmaceutics drug disposition classification system (BDDCS) to help predict the occurrence of idiosyncratic cutaneous adverse drug reactions associated with antiepileptic drug usage. AAPS J. 2016;18:757–66. https://doi.org/10.1208/s12248-016-9898-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Cheung CM, Huang JW, Ji C, Cheng B, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Huang YH, Lu CW, Yang CY, Lin YT, Chi MH, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Fan WL, Hung SI, Chung WH, Asian Severe Cutaneous Adverse Reaction Consortium. The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in asians: the major drug causality and comparison with the US FDA label. Clin Pharmacol Ther. 2019;105:112–20. https://doi.org/10.1002/cpt.1071.

Article  PubMed  Google Scholar 

Ambe K, Ohya K, Takada W, Suzuki M, Tohkin M. In silico approach to predict severe cutaneous adverse reactions using the Japanese adverse drug event report database. Clin Transl Sci. 2021;14:756–63. https://doi.org/10.1111/cts.12944.

Article  CAS  PubMed  PubMed Central  Google Scholar 

https://www.pmda.go.jp/safety/info-services/drugs/adr-info/suspected-adr/0003.html. Accessed 21 Jan 2024 (Japanese).

https://www.jmo.gr.jp/jmo/servlet/mdrLoginTop. Accessed 21 Apr 2022 (Japanese).

Jordan MH, Lewis MS, Jeng JG, Rees JM. Treatment of toxic epidermal necrolysis by burn units: another market or another threat? J Burn Care Rehabil. 1991;12:579–81. https://doi.org/10.1097/00004630-199111000-00015.

Article  CAS  PubMed